R.H. Bluestein & Co’s Merck MRK Stock Holding History

R.H. Bluestein & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-188,045	Closed	-$14.7M	–	419
2020 Q4	$14.7M	Buy	188,045 +37,329	+25%	+$2.85M	0.65%	48
2020 Q3	$11.9M	Buy	150,716 +17,698	+13%	+$1.39M	0.6%	44
2020 Q2	$9.81M	Buy	+133,018	New	+$10M	0.55%	54
2017 Q2	–	Sell	-5,298	Closed	-$321K	–	325
2017 Q1	$321K	Hold	5,298	–	–	0.02%	228
2016 Q4	$298K	Hold	5,298	–	–	0.02%	217
2016 Q3	$315K	Buy	5,298 +739	+16%	+$43.2K	0.02%	188
2016 Q2	$251K	Buy	+4,559	New	+$243K	0.02%	221
2014 Q3	–	Sell	-24,025	Closed	-$1.33M	–	374
2014 Q2	$1.33M	Buy	+24,025	New	+$1.31M	0.08%	87
2013 Q4	–	Sell	-21,956	Closed	-$997K	–	368
2013 Q3	$997K	Sell	21,956 -10,427	-32%	-$476K	0.07%	110
2013 Q2	$1.44M	Buy	+32,383	New	+$1.45M	0.13%	70

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

R.H. Bluestein & Co's MRK Position: Q1 2021 in Review

R.H. Bluestein & Co sold out of Merck (MRK) in Q1 2021, closing a stake of 188,045 shares — an estimated $14.7M sold.

R.H. Bluestein & Co first reported a position in MRK in Q2 2013 and held it in 10 quarters. The position peaked at $14.7M in Q4 2020. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

R.H. Bluestein & Co reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
R.H. Bluestein & Co sold 188,045 Merck shares in Q1 2021, an estimated $14.7M.
R.H. Bluestein & Co first reported a position in Merck in Q2 2013 and held it in 10 quarters.
R.H. Bluestein & Co's Merck position peaked at $14.7M in Q4 2020.
2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on R.H. Bluestein & Co's 13F filing for Q1 2021, filed 12 May 2021.